Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Schaaf

Showing results (121-130 of 180) with videos related to

Pageof 18
Sort By:
Eclinicalmedicine|January 23, 2024
Impaired lung function in adolescents with pulmonary tuberculosis during treatment and following treatment completionMarieke M van der Zalm, Vita W Jongen, Ruan Swanepoel, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2023
Optimizing dosing of the cycloserine pro-drug terizidone in children with rifampicin-resistant tuberculosisLouvina E van der Laan, Anthony J Garcia-Prats, Helen McIlleron, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2017
Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant TuberculosisPaolo Denti, Anthony J Garcia-Prats, Heather R Draper, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2019
Population Pharmacokinetics and Dosing of Ethionamide in Children with TuberculosisHenrik Bjugård Nyberg, Heather R Draper, Anthony J Garcia-Prats, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2017
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant TuberculosisLouvina E van der Laan, Anthony J Garcia-Prats, H Simon Schaaf, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 10, 2026
Treatment Outcomes and Drug-Related Adverse Events Across Four Short-Course RR-TB Regimens in South Africa: A Retrospective AnalysisNorbert Ndjeka, Rubeshan Perumal, Kamila Romanowski, et al.
Open Forum Infectious Diseases|August 28, 2025
Factors Predictive of Early Discontinuation of Preventive Treatment in Children With Household Exposure to Multidrug-resistant TuberculosisTrinh Duong, Joanna Brigden, Susan E Purchase, et al.
AIDS Research and Therapy|April 27, 2024
Severe BCG immune reconstitution inflammatory syndrome lymphadenitis successfully managed with pre-antiretroviral counseling and a non-surgical approach: a case reportPercina Machava, Winete Joaquim, Joseph Borrell, et al.
AIDS (London, England)|August 14, 2010
A randomized controlled trial of intermittent compared with daily cotrimoxazole preventive therapy in HIV-infected childrenHeather J Zar, Lesley Workman, Stanzi M le Roux, et al.
The Pediatric Infectious Disease Journal|May 19, 2023
Recurrent Tuberculosis Treatment Episodes in Children Presenting With Presumptive Pulmonary Tuberculosis in Cape Town, South AfricaCarla Mckenzie, H Simon Schaaf, Rolanda Croucamp, et al.
Pageof 18

Showing results (121-130 of 180) with videos related to

Sort By:
Pageof 18
Eclinicalmedicine|January 23, 2024
Impaired lung function in adolescents with pulmonary tuberculosis during treatment and following treatment completionMarieke M van der Zalm, Vita W Jongen, Ruan Swanepoel, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2023
Optimizing dosing of the cycloserine pro-drug terizidone in children with rifampicin-resistant tuberculosisLouvina E van der Laan, Anthony J Garcia-Prats, Helen McIlleron, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2017
Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant TuberculosisPaolo Denti, Anthony J Garcia-Prats, Heather R Draper, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2019
Population Pharmacokinetics and Dosing of Ethionamide in Children with TuberculosisHenrik Bjugård Nyberg, Heather R Draper, Anthony J Garcia-Prats, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2017
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant TuberculosisLouvina E van der Laan, Anthony J Garcia-Prats, H Simon Schaaf, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 10, 2026
Treatment Outcomes and Drug-Related Adverse Events Across Four Short-Course RR-TB Regimens in South Africa: A Retrospective AnalysisNorbert Ndjeka, Rubeshan Perumal, Kamila Romanowski, et al.
Open Forum Infectious Diseases|August 28, 2025
Factors Predictive of Early Discontinuation of Preventive Treatment in Children With Household Exposure to Multidrug-resistant TuberculosisTrinh Duong, Joanna Brigden, Susan E Purchase, et al.
AIDS Research and Therapy|April 27, 2024
Severe BCG immune reconstitution inflammatory syndrome lymphadenitis successfully managed with pre-antiretroviral counseling and a non-surgical approach: a case reportPercina Machava, Winete Joaquim, Joseph Borrell, et al.
AIDS (London, England)|August 14, 2010
A randomized controlled trial of intermittent compared with daily cotrimoxazole preventive therapy in HIV-infected childrenHeather J Zar, Lesley Workman, Stanzi M le Roux, et al.
The Pediatric Infectious Disease Journal|May 19, 2023
Recurrent Tuberculosis Treatment Episodes in Children Presenting With Presumptive Pulmonary Tuberculosis in Cape Town, South AfricaCarla Mckenzie, H Simon Schaaf, Rolanda Croucamp, et al.
Pageof 18